ISPE Tariff Forum Learning Level: Intermediate Session Length: 1.5 hours The ISPE Oral Solid Dosage (OSD) CoP Steering Committee will be hosting an open forum to discuss the current and potential impact of recently proposed...
Learning Level: Intermediate -
The SARS-CoV-2 worldwide pandemic has presented a significant challenge to business continuity for pharmaceutical manufacturing. It has led to Industry re-assessing the virus control framework, and in particular, any challenges that this may present to the mitigations currently in place. This presentation will focus on the SARS-CoV-2 situation and factors to be assessed in a GMP Biopharmaceutical manufacturing facility and whether they present a secure virus mitigation strategy to protect the product from contamination from this and other viruses.
- The factors involved in the virus control framework for a Biopharmaceutical manufacturing facility with reference to ICH Q5A.
- The planning activities required in order to prepare for a novel virus challenge to manufacturing facilities.
- Ongoing virus risk management and mitigations.
Speaker
Subscribe to your ISPE YouTube Channel
& Click the bell for notifications.
& Click the bell for notifications.
Past Webinars
Disruptive Medicine Innovation: Next Generation of Combination Product Technologies Complimentary Learning Level: Intermediate Session Length: 1 hour Combination products are emerging as innovative medical products due to...
AI/ML in Regulated Life Sciences (GxP) Sectors – Operation Phase: Maintaining a State of Control Complimentary Learning Level: Intermediate Session Length: 1.5 hours Guiding the pharmaceutical and medical device industries to...